SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $126,000 | 0.0% | 230,787 | -1.8% | 0.00% | – |
| Q1 2016 | $126,000 | -40.6% | 234,903 | -0.7% | 0.00% | – |
| Q4 2015 | $212,000 | +216.4% | 236,443 | +185.7% | 0.00% | – |
| Q3 2015 | $67,000 | -95.8% | 82,752 | -84.2% | 0.00% | -100.0% |
| Q2 2015 | $1,580,000 | +20.7% | 525,173 | -1.7% | 0.00% | 0.0% |
| Q1 2015 | $1,309,000 | -32.9% | 534,321 | -30.1% | 0.00% | -33.3% |
| Q4 2014 | $1,951,000 | +1975.5% | 764,890 | +5703.4% | 0.00% | – |
| Q3 2014 | $94,000 | -93.6% | 13,180 | -94.1% | 0.00% | -100.0% |
| Q2 2014 | $1,462,000 | -20.5% | 224,265 | -19.4% | 0.00% | -33.3% |
| Q1 2014 | $1,839,000 | -30.7% | 278,268 | -50.3% | 0.00% | -25.0% |
| Q4 2013 | $2,654,000 | +82.0% | 559,887 | +90.5% | 0.00% | +100.0% |
| Q3 2013 | $1,458,000 | +339.2% | 293,833 | +361.5% | 0.00% | +100.0% |
| Q2 2013 | $332,000 | – | 63,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |